CHEMOTHERAPY. Volume 6 Parasites, Fungi, and Viruses

Size: px
Start display at page:

Download "CHEMOTHERAPY. Volume 6 Parasites, Fungi, and Viruses"

Transcription

1 CHEMOTHERAPY Volume 6 Parasites, Fungi, and Viruses

2 CHEMOTHERAPY Volume 1 Clinical Aspects of Infections Prophylaxis; life-threatening infections; infection in leukaemia; surgical infection; anaerobic infection; respiratory and urinary tract infections; amikacin_ Volume 2 Laboratory Aspects of Infections Sensitivity testing; assay methods; animal models of infection; sisomycin; tobramycin. Volume 3 Volume 4 Special Problems in Chemotherapy Tuberculosis; genital tract infections; antibiotic resistance and mode of action; topical chemotherapy and antisepsis. Pharmacology of Antibiotics Tissue concentrations; pharmacokinetics; untoward effects of antibiotics. Volume 5 Penicillins and Cephalosporins Penicillins and cephalosporins; betalactamases; new agents. Volume 6 Parasites, Fungi, and Viruses Parasitic infections; fungal infections; chemotherapy of viruses; co-trimoxazole. Volume 7 Cancer Chemotherapy I Symposia - new drugs and approaches; cell and pharmacokinetics; potentiators of radiotherapy; in vitro screening systems; immunological aspects. Volume 8 Cancer Chemotherapy II Free papers - new drugs and approaches; cell and pharmacokinetics; mechanisms of action; new analogues; cancer chemotherapy of specific organs.

3 CHEMOTHERAPY Volutne 6 Parasites, Fungi, and Viruses Edited by J. D Williams The London Hospital Medical College London, U.K. and A.M. Geddes East Birmingham Hospital Birmingham, U. K. Springer Science+Business Media, LLC

4 Library of Congress Cataloging in Publication Data International Congress of Chemotherapy, 9th, London, Parasites, fungi, and viruses. (Chemotherapy;v.6) Includes index. 1. Chemotherapy-Congresses. 2. Anti-infective agents-congresses. I. Williams, John David, M.D. I1. Geddes, Alexander McIntosh. III. Title. IV. Series. RM260.2.C45 vol '.58s [616.9'6'061] ISBN ISBN (ebook) DOI / Proceedings of the Ninth International Congress of Chemotherapy held in London, July, 1975 will be published in eight volumes, of which this is volume six Springer Science+Business Media New York Originally published by Plenum Press, New York in Softcover reprint of the hardcover 1 st edition 1976 United Kingdom edition published by Plenum Press, London A Division of Plenum Publishing Company, Ltd. Davis House (4th Floor), 8 Scrubs Lane, Harlesden, London, MW10 6SE, England All rights reserved No part of this book may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise, without written permission from the Publisher

5 CHEMOTHERAPY Proceedings of the 9th International Congress of Chemotherapy held in London, July, 1975 A. M. Geddes (Antimicrobial) East Birmingham Hospital. W. Brumfitt K.HeIlmann K.D. Bagshawe H.Smith EJ.Stokes F. Wrigley J.D. Williams Editorial Committee K. Hellmann, Chairman (Anticancer) Imperial Cancer Research Fund, London. J. D. Williams (Antimicrobial) The London Hospital Medical College. Congress Organising Committee I. Phillips M.R.W. Brown D.G.James C. Stuart Harris R.G.Jacomb D.T.D. Hughes T.Connors H.P. Lambert P.Tumer A.M. Geddes D.Armitage D.Crowther D.8.R_s R.E.O. Williams International Society of Chemotherapy Executive - to July 1975 P.Ma1ek C.Grassi G.B. Werner HoP. Kuemmerle Z.Modr K.H.Spitzy P. Rentchnick H. Ericsson G.M.Savage H. Umezawa

6 Preface The International Society of Chemotherapy meets every two years to review progress in chemotherapy of infections and of malignant disease. Each meeting gets larger to encompass the extension of chemotherapy into new areas. In some instances, expansion has been rapid, for example in cephalosporins, penicillins and combination chemotherapy of cancer - in others slow, as in the field of parasitology. New problems of resistance and untoward effects arise; reduction of host toxicity without loss of antitumour activity by new substances occupies wide attention. The improved results with cancer chemotherapy, especially in leukaemias, are leading to a greater prevalence of severe infection in patients so treated, pharmacokinetics of drugs in normal and diseased subjects is receiving increasing attention along with related problems of bioavailability and interactions between drugs. Meanwhile the attack on some of the major bacterial infections, such as gonorrhoea and tuberculosis, which were among the first infections to feel the impact of chemotherapy, still continue to be major world problems and are now under attack with new agents and new methods. From this wide field and the 1,000 papers read at the Congress we have produced Proceedings which reflect the variety and vigour of research in this important field of medicine. It was not possible to include all of the papers presented at the Congress but we have attempted to include most aspects of current progress in chemotherapy. We thank the authors of these communications for their cooperation in enabling the Proceedings to be available at the earliest possible date. The method of preparation does not allow for uniformity of typefaces and presentation of the material and we hope that the blemishes of language and typographical errors do not detract from the understanding of the reader and the importance of the Proceedings. K. HELLMANN, Imperial Cancer Research Fund A. M. GEDDES, East Birmingham Hospital J. D. WILLIAMS, The London Hospital Medical College vii

7 Contents What Are the Problems in Tropical In~ections?. 1 A. Bryceson Epidemic Diseases. D. A. Warrell, P. L. Perine, and D. W. Krause Progress Achieved in the Chemotherapy o~ Soil Transmitted Helminths. F. Ar~aa and I. Farahmandian The Treatment o~ Chloroquine-Resistant Falciparum Malaria.. A. P. Hall The Role o~ University Research Departments in the Development o~ Antiparasitic Chemotherapy W. Peters Current Problems in the Chemotherapy o~ Parasitic Diseases - The Role o~ the Pharmaceutical Industry O. D. Standen New Nitroimidazoles with a Chemotherapeutic Activity E. Winkelmann and W. Raether New 5-Nitroimidazoles with Antiprotozoal Activity: E~~ect o~ Hoe 088 (Pirinidazole) W. Raether and E. Winkelmann Pharmacokinetic and Metabolic Studies with Ornidazole in Man. Comparison with Metronidazole D. E. Schwartz and F. Jeunet The Diagnosis and Treatment o~ Lambliasis W. Altor~er ix

8 x Treatment of Giardiasis with a Single Oral Dose of Tinidazole T. Pettersson CONTENTS A Rural Study in Tanzania of the Chemosuppressant Activity of Various Regimes of Co-Trimoxazole or Chloroquine in Subjects with f. falciparum Parasi taemia 69 Th. J. Goosen, M. A. L. Goosen, and A. J. Salter Results of the Anti-X. cruzi Activity of Ro in Man J. A. Cerisola, C. A. Barclay, H. Lugones, and O. Ledesma 79 The Efficiency of Metronidazole "Flagyl" Against Trypanosoma evansi In Vivo 87 A. M. Mandour and A. M. Abd-El Rahman Emericid ( R.P.): A New Anticoccidial F. Benazet, J. R. Cartier, J. Florent, C. Johnson, J. Lunel, and D. Mancy Efficiency of Levamisole "Ketrax" on Some Nematode Infections in Assiut Province A. M. Mandour and L. A. M. Omran Review of Amphotericin B J. E. Bennett Polyenes: Actions and Prospects D. Kerridge and N. J. Russell Review of Imidazole Group R. J. Holt MOde of Action and Resistance to 5-Fluorocytosine 127 J. Schonebeck Combination of Amphotericin B and 5-Fluorocytosine A. Polak and H. J. Scholer 137 Combined Flucytosine - Amphotericin B Treatment of Cryptococcosis 143 J. P. Utz, I. L. Garriques, M. A. Sande, J. F. Warner, G. L. Mandell, R. F. McGehee, R. J. Duma, and S. Shadomy

9 CONTENTS The Tissue Culture Study of Antifungal Agents and Their Morphological Changes on Yeast and Yeast-Like Fungi A. Uetsuka, S. Satoh, M. Itoh, N. Oka~aki, Y. Ohno, and K. Yoshimura 157 xi Miconazole Plasma Levels in Healthy Subjects and in Patients with Impaired Renal Function J. Boelaert, R. Daneels, and H. Van Landuyt, and J. Symoens In Vitro Studies with Miconazole and Miconazole Ni trate S. Shadomy and L. Paxton 171 Clinical Studies with Clotrimazole: Efficacy, Tolerance H. Weuta Pharmacokinetics, 179 Oral Clotrimazole in the Treatment of Fungal Infection R. Y. Cartwright Clotrimazole (Canesten) Therapy of Fungal Keratitis D. B. Jones, B. R. Jones, and N. M. Robinson Replication of Picornaviruses F. Brown Molecular Biology of Influenza Virus Replication and Points of Action of Inhibitors J. S. Oxford Metalloenzymes: A New Focus for Antiviral Drug Design? 209 D. D. Perrin Inhibition of Influenza Virus Replication by 2-deoxY-2,3- dehydro-n-trifluoroacetylneuraminic Acid (FANA) 215 J. L. Schulman and P. Palese Virus Specified Enzymes in Herpes Simplex Virus Infected Cells.. J. H. Subak-Sharpe and J. Hay 219 Studies with IBT-Resistant and IBT-Dependent Mutants of Vaccinia Virus to Clarify the Mechanism of the Antipox Activity 227 E. Katz, E. Margalith, B. Winer, H. Felix, and N. Goldblum

10 xii The Role of Cell-Mediated Immunity in the Therapeutic Action of Isoprinosine of Viral Disease Processes A. J. Glasky, G. E. Friebertshauer,J. W. Holker, R. A. Settineri, and T. Ginsberg CONTENTS 235 Bonaphton - A New Antiviral Chemotherapeutic Drug 239 G. N. Pershin, N. S. Bogdanova, I. S. Nikolaeva, A. N. Grinev, G. Ya. Uretskaya, and N. V. Arkhangelskaya Chemotherapeutic Activity of Bonaphton in Herpetic Keratitis in Rabbits N. S. Bogdanova, I. S. Nikolayeva, S. M. Kutchak, and G. N. Per shin Effect of Ribavirin on Influenza Virus Infection in Ferrets.. K. P. Schofield, C. W. Potter, J. P. Phair, J. S. Oxford, and R. Jennings I. C. I A Potent Anti-Rhinovirus Compound D. L. Swallow, R. A. Bucknall, W. E. Stanier, A. Hutchinson, and H. Gaskin Assessment of Some Antirhinovirus Compounds in Tissue Culture and Against Experimental Challenge in Volunteers. S. E. Reed and D. A. J. Tyrrell The Potential of Nucleosides as Antiviral Agents R. W. Sidwell, L. B. Allen, J. H. Huffman, J. T. Witkowski, P. D. Cook, R. L. Tolman, G. R. Revankar, L. N. Simon, and R. K. Robins Bichlorinated Pyrimidines as Possible Antiviral Agents 295 P. La Colla, M. A. Marcialis, O. Flore, A. Firinu, A. Garzia, and B. Loddo Experimental Chemotherapy of Arbovirus Infections 303 A. N. Fomina and A. K. Schubladze The Use of Lung Weight Changes for Evaluating the Activity of Drugs Against Influenza Infections in the Mouse 307 M. F. Beeson and M. R. Boyd In Vivo Topical Activity of the Interferon Inducer BRL 5907 and Ribavirin in Ferrets Infected with Influenza Virus 313 M. R. Boyd and M. F. Beeson

11 CONTENTS of Pyrimidine Derivatives on RNA Dependent RNA Polymerase o~ Mengovirus In~ected FL Cells E. M. Tonew and B. Fahlbusch E~~ects "In Vivo" Depression of Either Endotoxin or Virus Induced Inter~erons by Ri~ampicin and Ri~amycin Derivatives E. Ronda, M. L. Alonso, and I. Barasoain Investigations upon the Mode of Action o~ Compound 48/80 on ss DNA o~ Phage ~Xl74. R. Dennin Anti-Herpes Simplex Virus (HSV) E~fect of Amphotericin B Methyl Ester In Vivo H. Shiota, B. R. Jones, and C. P. Scha~fner Comparative Drug Trial in Cholera A. F. B. Mabadeje Trimethoprim Resistance o~ Pathogenic Organisms Previous to Common Clinical Use o~ Sulprim S. Ortel Susceptibility o~ Chloramphenicol-Resistant Strains of Salmonella typhi to Trimethoprim/ Sulfamethoxazole. M. B. Bushby and S. R. M. Bushby xiii Activity o~ Trimethoprim and Sulphonamides Against Pseudomonas aeruginosa D. Gray and J. M. T. Hamilton-Miller Microbiological and Clinical Studies with Co-Trimoxazole M. Aguirre, J. M. Ales, F. Lahoz, and R. Vela Cotrimoxazole as an All-Purpose Antibacterial Agent J. C. Gould and B. Watt Treatment o~ Human Brucellosis with Doxycycline and Trimethoprim-Sulfonamide L. Telegdy and J. Keri Synergy and Prostatitis S. R. M. Bushby and M. B. Bushby Trimethoprim/Sul~amethoxazole

12 xiv The Concentration of Sulphamethoxazole and Trimethoprim in Human Prostate Gland W. Oosterlinck, R. Defoort, and G. Renders Long-Term Treatment with the Combination SMZ/TMP in Children with Urinary Tract Infections L. B. Hahn and C. A. Barclay Long-Term Low-Dosage Co-Trimoxazole in the Management of Urinary Tract Infection in Children J. M. Smellie, R. N. GrUneberg, A. Leakey, and W. S. Atkin A Double-Blind study of Sulfamethoxazole Trimethoprim vs. Its Components in Chronic Urinary Tract Infections C. Demos, J. Pinderhughes, and M. Oakes A New Combination of Trimethoprim and a Sulphonamide (Sulphadiazine) in Urinary Tract Infections, a Double-Blind Study A. Lovestad, B. Gastrin, and R. LundstrOm CONTENTS Comparative Clinical Trial of Parenteral Co-Trimoxazole in Major Respiratory Infections: 421 M. Janousek, L. Corbeel, and P. Stenier List of Contributors 433

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology Zeina Alkudmani Chemotherapy Definitions The use of any chemical (drug) to treat any disease or condition. Chemotherapeutic Agent Any drug

More information

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How

More information

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Introduction to Chemotherapeutic Agents Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Antimicrobial Agents Substances that kill bacteria without harming the host.

More information

Antimicrobial Therapy

Antimicrobial Therapy Chapter 12 The Elements of Chemotherapy Topics - Antimicrobial Therapy - Selective Toxicity - Survey of Antimicrobial Drug - Microbial Drug Resistance - Drug and Host Interaction Antimicrobial Therapy

More information

ESSENTIALS OF ANTIMICROBIAL PHARMACOLOGY

ESSENTIALS OF ANTIMICROBIAL PHARMACOLOGY ESSENTIALS OF ANTIMICROBIAL PHARMACOLOGY Essentials of Antimicrobial Pharmacology A Guide to Fundamentals for Practice PAUL H. AXELSEN, MD University of Pennsylvania School of Medicine Philadelphia, PA

More information

Chapter 12. Antimicrobial Therapy. Antibiotics 3/31/2010. Spectrum of antibiotics and targets

Chapter 12. Antimicrobial Therapy. Antibiotics 3/31/2010. Spectrum of antibiotics and targets Chapter 12 Topics: - Antimicrobial Therapy - Selective Toxicity - Survey of Antimicrobial Drug - Microbial Drug Resistance - Drug and Host Interaction Antimicrobial Therapy Ehrlich (1900 s) compound 606

More information

CHEMOTHERAPY. Volume 4 Pharmacology of Antibiotics

CHEMOTHERAPY. Volume 4 Pharmacology of Antibiotics CHEMOTHERAPY Volume 4 Pharmacology of Antibiotics CHEMOTHERAPY Volume 1 Clinical Aspects of Infections Prophylaxis; life-threatening infections; infection in leukaemia; surgical infection; anaerobic infection;

More information

Pharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE

Pharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE Pharm 262: 1 Pharmaceutical Microbiology II Antibiotics DR. C. AGYARE Reference Books 2 HUGO, W.B., RUSSELL, A.D. Pharmaceutical Microbiology. 6 th Ed. Malden, MA: Blackwell Science, 1998. WALSH, G. Biopharmaceuticals:

More information

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد م. مادة االدوية المرحلة الثالثة م. غدير حاتم محمد 2017-2016 ANTIMICROBIAL DRUGS Antimicrobial drugs Lecture 1 Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease. Antimicrobial drugs:

More information

Principles of Antimicrobial therapy

Principles of Antimicrobial therapy Principles of Antimicrobial therapy Laith Mohammed Abbas Al-Huseini M.B.Ch.B., M.Sc, M.Res, Ph.D Department of Pharmacology and Therapeutics Antimicrobial agents are chemical substances that can kill or

More information

Antibiotics A Multidisciplinary Approach

Antibiotics A Multidisciplinary Approach Antibiotics A Multidisciplinary Approach Antibiolies A Multidisciplinary Approach Giancarlo Lancini Marion Merrell Dow Research Institute (MMDRI) Lepetit Research Center Gerenzano (Varese), Italy Francesco

More information

Terry Talks Nutrition: Infectious microbes

Terry Talks Nutrition: Infectious microbes Terry Talks Nutrition: Infectious microbes Meet the Microbes Microbes = very tiny living things that can only be seen under a microscope 4 types of disease-causing microbes Bacteria Viruses Yeast (fungi)

More information

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical

More information

Foundation in Pharmacology - 2 (Year 3 Semester 1)

Foundation in Pharmacology - 2 (Year 3 Semester 1) Foundation in - 2 (Year 3 Semester 1) Credits: 0.5 Foundation in - 2 (Credits: 2.0 Foundation in 1) Duration: 3 weeks (15 days) Topic & Concepts Objectives Time Dept. T/L activity Comments At the end of

More information

Lecture 6: Fungi, antibiotics and bacterial infections. Outline Eukaryotes and Prokaryotes Viruses Bacteria Antibiotics Antibiotic resistance

Lecture 6: Fungi, antibiotics and bacterial infections. Outline Eukaryotes and Prokaryotes Viruses Bacteria Antibiotics Antibiotic resistance Lecture 6: Fungi, antibiotics and bacterial infections Outline Eukaryotes and Prokaryotes Viruses Bacteria Antibiotics Antibiotic resistance Lecture 1 2 3 Lecture Outline Section 4 Willow and aspirin Opium

More information

Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija

Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija Microbiology : antimicrobial drugs Sheet 11 Ali abualhija return to our topic antimicrobial drugs, we have finished major group of antimicrobial drugs which associated with inhibition of protein synthesis

More information

running head: SUPERBUGS Humphreys 1

running head: SUPERBUGS Humphreys 1 running head: SUPERBUGS Humphreys 1 Superbugs GCH 360 Term Paper Assignment Kelly Humphreys April 30, 2014 SUPERBUGS Humphreys 2 Introduction The World Health Organization (WHO) recognizes antibiotic resistance

More information

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems Micro 301 Antimicrobial Drugs 11/7/12 Significance of antimicrobial drugs Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems Definitions Antibiotic Selective

More information

R-factor mediated trimethoprim resistance: result of two three-month clinical surveys

R-factor mediated trimethoprim resistance: result of two three-month clinical surveys Journal of Clinical Pathology, 1978, 31, 850-854 R-factor mediated trimethoprim resistance: result of two three-month clinical surveys S. G. B. AMYES1, A. M. EMMERSON2, AND J. T. SMITH3 From the 'Department

More information

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016 Selective toxicity Antimicrobial Drugs Chapter 20 BIO 220 Drugs must work inside the host and harm the infective pathogens, but not the host Antibiotics are compounds produced by fungi or bacteria that

More information

Emerging Issues and Controversies in Infectious Disease

Emerging Issues and Controversies in Infectious Disease Emerging Issues and Controversies in Infectious Disease Emerging Infectious Diseases of the 21st Century I.W. Fong Professor of Medicine, University of Toronto Infectious Diseases, St. Michael s Hospital

More information

number Done by Corrected by Doctor Dr Hamed Al-Zoubi

number Done by Corrected by Doctor Dr Hamed Al-Zoubi number 8 Done by Corrected by Doctor Dr Hamed Al-Zoubi 25 10/10/2017 Antibacterial therapy 2 د. حامد الزعبي Dr Hamed Al-Zoubi Antibacterial therapy Figure 2/ Antibiotics target Inhibition of microbial

More information

Controlling Microbial Growth in the Body: Antimicrobial Drugs

Controlling Microbial Growth in the Body: Antimicrobial Drugs Controlling Microbial Growth in the Body: Antimicrobial Drugs Chapter 12 Topics - Antimicrobial Therapy - Selective Toxicity - Survey of Antimicrobial Drug - Microbial Drug Resistance - Drug and Host Interaction

More information

Chapter 51. Clinical Use of Antimicrobial Agents

Chapter 51. Clinical Use of Antimicrobial Agents Chapter 51 Clinical Use of Antimicrobial Agents History of antimicrobial therapy Early 17 th century Cinchona bark was used as an important historical remedy against malaria. 1909 Paul Ehrlich sought a

More information

Chapter 46. Learning Objectives (cont d)

Chapter 46. Learning Objectives (cont d) Chapter 46 Antimicrobial Agents Learning Objectives Explain the major action and effects of drugs used to treat infectious diseases Identify criteria used to select an effective antimicrobial agent Identify

More information

Proceedings of the 13th International Congress of the World Equine Veterinary Association WEVA

Proceedings of the 13th International Congress of the World Equine Veterinary Association WEVA www.ivis.org Proceedings of the 13th International Congress of the World Equine Veterinary Association WEVA October 3-5, 2013 Budapest, Hungary Reprinted in IVIS with the Permission of the WEVA Organizers

More information

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017 Antibiotics Antimicrobial Drugs Chapter 20 BIO 220 Antibiotics are compounds produced by fungi or bacteria that inhibit or kill competing microbial species Antimicrobial drugs must display selective toxicity,

More information

Chapter concepts: What are antibiotics, the different types, and how do they work? Antibiotics

Chapter concepts: What are antibiotics, the different types, and how do they work? Antibiotics Chapter concepts: Antibiotics What are antibiotics, the different types, and how do they work? How do we decided on the most appropriate antibiotic treatment? What are some of the ways that bacteria are

More information

Chemotherapeutic Agents

Chemotherapeutic Agents Chemotherapeutic Agents The cell is the basic structure of all living organisms. The cell membrane features specifi c receptor sites that allow interaction with various chemicals, histocompatibility proteins

More information

Antibiotics. Simplified. Jason C. Gallagher PharmD, BCPS. Conan MacDougall PharmD, MAS, BCPS. Clinical Associate Professor Temple University

Antibiotics. Simplified. Jason C. Gallagher PharmD, BCPS. Conan MacDougall PharmD, MAS, BCPS. Clinical Associate Professor Temple University Antibiotics Simplified third EDITION Jason C. Gallagher PharmD, BCPS Conan MacDougall PharmD, MAS, BCPS Clinical Associate Professor Temple University Associate Professor of Clinical Pharmacy School of

More information

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1 Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali Lec 1 28 Oct 2018 References Lippincott s IIIustrated Reviews / Pharmacology 6 th Edition Katzung and Trevor s Pharmacology / Examination

More information

DEPARTMENT OF MEDICAL MICROBIOLOGY

DEPARTMENT OF MEDICAL MICROBIOLOGY 1. Title of Subject: Tumor viruses and oncogenes DEPARTMENT OF MEDICAL MICROBIOLOGY semester: 2 nd Coordinator: Dr. György Veress Instructors: Dr. György Veress Entrance conditions: Final exam from Medical

More information

INFECTION CONTROL IN THE ICU ENVIRONMENT

INFECTION CONTROL IN THE ICU ENVIRONMENT INFECTION CONTROL IN THE ICU ENVIRONMENT PERSPECTIVES ON CRITICAL CARE INFECTIOUS DISEASES Jordi Rella, M.D., Series Editor t. N. Singh and J.M. Aguado (eels.): Infectious Complications in Transplant Recipients.

More information

Chapter 20. Antimicrobial Drugs. Lectures prepared by Christine L. Case Pearson Education, Inc. Lectures prepared by Christine L.

Chapter 20. Antimicrobial Drugs. Lectures prepared by Christine L. Case Pearson Education, Inc. Lectures prepared by Christine L. Chapter 20 Antimicrobial Drugs Lectures prepared by Christine L. Case Copyright Lectures prepared by Christine L. Case The History of Chemotherapy Learning Objectives 20-1 Identify the contributions of

More information

Antimicrobial Drugs. PowerPoint Lecture Presentations prepared by Bradley W. Christian, McLennan Community College C H A P T E R

Antimicrobial Drugs. PowerPoint Lecture Presentations prepared by Bradley W. Christian, McLennan Community College C H A P T E R PowerPoint Lecture Presentations prepared by Bradley W. Christian, McLennan Community College C H A P T E R 20 Antimicrobial Drugs The History of Chemotherapy Selective toxicity: selectively finding and

More information

Antimicrobial agents. are chemicals active against microorganisms

Antimicrobial agents. are chemicals active against microorganisms Antimicrobial agents are chemicals active against microorganisms Antibacterial Agents Are chemicals active against bacteria Antimicrobials Antibacterial Antifungal Antiviral Antiparasitic: -anti protozoan

More information

General Approach to Infectious Diseases

General Approach to Infectious Diseases General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMP/627/01-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE DEMONSTRATION OF EFFICACY

More information

Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani

Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani 30-1-2018 1 Objectives of the lecture At the end of lecture, the students should be able to understand the following:

More information

Analysis of Antibiotic/ Drug Residues in Food Products of Animal Origin

Analysis of Antibiotic/ Drug Residues in Food Products of Animal Origin Analysis of Antibiotic/ Drug Residues in Food Products of Animal Origin Analysis of Antibiotic/Drug Residues in Food Products of Animal Origin Edited by Vipin K. Agarwal The Conneclicut Agricullu1'lll

More information

GENERAL NOTES: 2016 site of infection type of organism location of the patient

GENERAL NOTES: 2016 site of infection type of organism location of the patient GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered

More information

Xochitl Morgan: The human microbiome; the role of commensals in health and disease.

Xochitl Morgan: The human microbiome; the role of commensals in health and disease. MICR332: Health Microbiology 18 points; Semester 2 Course prescription: Disease mechanisms of key microbial pathogens, including bacteria, protozoa, and fungi. Treatment and control of microbial diseases.

More information

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi Antibacterial therapy 1 د. حامد الزعبي Dr Hamed Al-Zoubi ILOs Principles and terms Different categories of antibiotics Spectrum of activity and mechanism of action Resistancs Antibacterial therapy What

More information

Antibacterial Agents & Conditions. Stijn van der Veen

Antibacterial Agents & Conditions. Stijn van der Veen Antibacterial Agents & Conditions Stijn van der Veen Antibacterial agents & conditions Antibacterial agents Disinfectants: Non-selective antimicrobial substances that kill a wide range of bacteria. Only

More information

Guidelines for Antimicrobial treatment for treatment of confirmed infections adults

Guidelines for Antimicrobial treatment for treatment of confirmed infections adults Guidelines for Antimicrobial treatment for treatment of confirmed infections adults This guideline gives recommendations for treatment of confirmed infections in adults for children please see the Paediatric

More information

Practical part: Evaluation of microbial cell morphology under the light microscope and practice of Gram staining technique.

Practical part: Evaluation of microbial cell morphology under the light microscope and practice of Gram staining technique. MEDICAL UNIVERSITY OF BIALYSTOK DEPARTMENT OF MICROBIOLOGY Mickiewicza 2 C, BIALYSTOK 15-222 tel./fax +48 (85) 748 5562 Course: Microbiology Program of classes: 2017 / 2018 Winter/Summer semester - 15

More information

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vetrisulf powder for oral solution for chickens, turkeys and geese

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vetrisulf powder for oral solution for chickens, turkeys and geese SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vetrisulf powder for oral solution for chickens, turkeys and geese 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One g contains:

More information

Other Beta - lactam Antibiotics

Other Beta - lactam Antibiotics Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics

More information

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory

More information

Comparison of antibiotic susceptibility results obtained with Adatab* and disc methods

Comparison of antibiotic susceptibility results obtained with Adatab* and disc methods J Clin Pathol 1984;37:159-165 Comparison of antibiotic susceptibility results obtained with Adatab* and disc methods JJS SNELL, MVS DANVERS, PS GARDNER From the Division of Microbiological Reagents and

More information

Pharmacology Week 6 ANTIMICROBIAL AGENTS

Pharmacology Week 6 ANTIMICROBIAL AGENTS Pharmacology Week 6 ANTIMICROBIAL AGENTS Mechanisms of antimicrobial action Mechanisms of antimicrobial action Bacteriostatic - Slow or stop bacterial growth, needs an immune system to finish off the microbe

More information

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1 Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director

More information

Fingernails. Smooth (no pits or grooves) Uniform in color Have no spots or discoloration

Fingernails. Smooth (no pits or grooves) Uniform in color Have no spots or discoloration Fingernail Problems Fingernails Fingernails are made from a protein called keratin New nail cells form at the base of the nail under the cuticle As the cells grow older, they harden and get pushed out

More information

Is erythromycin bactericidal

Is erythromycin bactericidal Is erythromycin bactericidal Search Comparison of erythromycin, clarithromycin, azithromycin, telithromycin, roxithromycin: mechanism of action, spectrum of activity, side effects, drug interactions. Erythromycin

More information

ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae

ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae Thomas Durand-Réville 02 June 2017 - ASM Microbe 2017 (Session #113) Disclosures Thomas Durand-Réville: Full-time Employee; Self;

More information

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut This presentation Definitions needed to discuss antimicrobial resistance

More information

EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia

EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia Background The Expert Advisory Group on Antimicrobial Resistance of the NH&MRC provides advice to Australian governments and

More information

Antimicrobials & Resistance

Antimicrobials & Resistance Antimicrobials & Resistance History 1908, Paul Ehrlich - Arsenic compound Arsphenamine 1929, Alexander Fleming - Discovery of Penicillin 1935, Gerhard Domag - Discovery of the red dye Prontosil (sulfonamide)

More information

folate-derived cofactors purines pyrimidines Sulfonamides sulfa drugs Trimethoprim infecting bacterium to perform DNA synthesis cotrimoxazole

folate-derived cofactors purines pyrimidines Sulfonamides sulfa drugs Trimethoprim infecting bacterium to perform DNA synthesis cotrimoxazole Folate Antagonists Enzymes requiring folate-derived cofactors are essential for the synthesis of purines and pyrimidines (precursors of RNA and DNA) and other compounds necessary for cellular growth and

More information

New Insights into the Treatment of Leishmaniasis

New Insights into the Treatment of Leishmaniasis New Insights into the Treatment of Leishmaniasis Eric Zini Snow meeting, 14 March 2009 Few drugs available for dogs Initially developed to treat human leishmaniasis, later adopted in dogs None eradicates

More information

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Gram-positive cocci: Staphylococcus aureus: *Resistance to penicillin is almost universal. Resistance

More information

WHY IS THIS IMPORTANT?

WHY IS THIS IMPORTANT? CHAPTER 20 ANTIBIOTIC RESISTANCE WHY IS THIS IMPORTANT? The most important problem associated with infectious disease today is the rapid development of resistance to antibiotics It will force us to change

More information

Small Animal Oncology

Small Animal Oncology Small Animal Oncology Small Animal Oncology Joanna Morris Formerly of Department of Clinical Veterinary Medicine, University of Cambridge Veterinary School and Jane Dobson Department of Clinical Veterinary

More information

Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu

Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu Search for: Search Search Does levaquin cover anaerobes Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu Levofloxacin, sold under the trade names Levaquin among others, is an antibiotic.

More information

Approved by the Food Safety Commission on September 30, 2004

Approved by the Food Safety Commission on September 30, 2004 Approved by the Food Safety Commission on September 30, 2004 Assessment guideline for the Effect of Food on Human Health Regarding Antimicrobial- Resistant Bacteria Selected by Antimicrobial Use in Food

More information

THE QUINOLONES. Third Edition. Edited by VINCENT T. ANDRIOLE. Yale University School of Medicine ACADEMIC PRESS

THE QUINOLONES. Third Edition. Edited by VINCENT T. ANDRIOLE. Yale University School of Medicine ACADEMIC PRESS THE QUINOLONES Third Edition Edited by VINCENT T. ANDRIOLE Yale University School of Medicine ACADEMIC PRESS San Diego London Boston New York Sydney Tokyo Toronto CONTENTS Contrihuttirs Prc face xv xix

More information

Aminoglycosides. Spectrum includes many aerobic Gram-negative and some Gram-positive bacteria.

Aminoglycosides. Spectrum includes many aerobic Gram-negative and some Gram-positive bacteria. Aminoglycosides The only bactericidal protein synthesis inhibitors. They bind to the ribosomal 30S subunit. Inhibit initiation of peptide synthesis and cause misreading of the genetic code. Streptomycin

More information

Curricular Components for Infectious Diseases EPA

Curricular Components for Infectious Diseases EPA Curricular Components for Infectious Diseases EPA 1. EPA Title Promoting antimicrobial stewardship based on microbiological principles 2. Description of the A key role for subspecialists is to utilize

More information

1. A patient with an allergy to sulfa (sulfonamides) should not take A) Augmentin. B) tetracycline. C) minocycline D) Bactrim DS.

1. A patient with an allergy to sulfa (sulfonamides) should not take A) Augmentin. B) tetracycline. C) minocycline D) Bactrim DS. Name: Date: 1. A patient with an allergy to sulfa (sulfonamides) should not take A) Augmentin. B) tetracycline. C) minocycline D) Bactrim DS. 2. An example of a drug that should not be used in children

More information

Considerations in antimicrobial prescribing Perspective: drug resistance

Considerations in antimicrobial prescribing Perspective: drug resistance Considerations in antimicrobial prescribing Perspective: drug resistance Hasan MM When one compares the challenges clinicians faced a decade ago in prescribing antimicrobial agents with those of today,

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit EMEA/MRL/389/98-FINAL July 1998 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS ENROFLOXACIN (extension to

More information

Atlas of Experimental Toxicological Pathology

Atlas of Experimental Toxicological Pathology Atlas of Experimental Toxicological Pathology To Cora P. Cherry for sharing with us her wealth of experience in the field of toxicological pathology Current Histopathology Consultant Editor Professor G.

More information

Antimicrobial Update Stewardship in Primary Care. Clare Colligan Antimicrobial Pharmacist NHS Forth Valley

Antimicrobial Update Stewardship in Primary Care. Clare Colligan Antimicrobial Pharmacist NHS Forth Valley Antimicrobial Update Stewardship in Primary Care Clare Colligan Antimicrobial Pharmacist NHS Forth Valley Setting the Scene! Consequences of Antibiotic Use? Resistance For an individual patient with

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Active substance: cefalexin (as cefalexin monohydrate) mg

SUMMARY OF PRODUCT CHARACTERISTICS. Active substance: cefalexin (as cefalexin monohydrate) mg SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cefaseptin 750 mg tablets for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One tablet contains: Active substance: cefalexin

More information

ANTIBIOTIC RESISTANCE. Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh

ANTIBIOTIC RESISTANCE. Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh ANTIBIOTIC RESISTANCE Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh WHY IS THIS IMPORTANT? The most important problem associated with infectious disease today is the rapid development

More information

ANTIMICROBIAL DOSING GUIDE 2013

ANTIMICROBIAL DOSING GUIDE 2013 page 1 / 5 page 2 / 5 antimicrobial dosing guide 2013 pdf Stanford Hospital & Clinics Aminoglycoside Dosing Guidelines 2013 I. DETERMINING DOSE AND CREATININE CLEARANCE: 1. Use of ideal body weight (IBW)

More information

Health Products Regulatory Authority

Health Products Regulatory Authority 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Genta 50 mg/ml solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active Substances Gentamicin sulphate equivalent to Gentamicin

More information

JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro

JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro Journal of Antimicrobial Chemotherapy (1997) 39, 713 717 JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro Ian Morrissey* Department of Biosciences, Division of Biochemistry

More information

Marc Decramer 3. Respiratory Division, University Hospitals Leuven, Leuven, Belgium

Marc Decramer 3. Respiratory Division, University Hospitals Leuven, Leuven, Belgium AAC Accepts, published online ahead of print on April 0 Antimicrob. Agents Chemother. doi:./aac.0001- Copyright 0, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

More information

Comparative studies on pulse and continuous oral norfloxacin treatment in broilers and turkeys. Géza Sárközy

Comparative studies on pulse and continuous oral norfloxacin treatment in broilers and turkeys. Géza Sárközy Comparative studies on pulse and continuous oral norfloxacin treatment in broilers and turkeys Géza Sárközy Department of Pharmacology and Toxicology Faculty of Veterinary Science Szent István University

More information

Antibiotics have no (or only minimal) effect on human cells and tissues - their action is directed specifically against micro-organisms.

Antibiotics have no (or only minimal) effect on human cells and tissues - their action is directed specifically against micro-organisms. 1989 Elsevier Science Publishers B V (Biomedical Division) Dose-response relationships in clinical pharmacology. L Lasagna, S Enll, C.A NaranjOj editors 293 DOSE-RESPONSE RELATIONSHIPS IN ANTIMICROBIAL

More information

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how? Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how? Andrea Duppenthaler andrea.duppenthaler@insel.ch Limping patient local pain swelling tenderness warmth fever acute Osteomyelitis

More information

Protein Synthesis Inhibitors

Protein Synthesis Inhibitors Protein Synthesis Inhibitors Assistant Professor Dr. Naza M. Ali 11 Nov 2018 Lec 7 Aminoglycosides Are structurally related two amino sugars attached by glycosidic linkages. They are bactericidal Inhibitors

More information

Pharmacokinetics. Antibiotics and Chemotherapy. Vol. 25

Pharmacokinetics. Antibiotics and Chemotherapy. Vol. 25 Pharmacokinetics Antibiotics and Chemotherapy Vol. 25 Series Editors H. SCHNFELD, Grenzach; R. W. BROCKMAN, Birmingham, Ala, and F.E. HAHN, Washington, D.C. S. Karger Basel Mnchen. Paris London New York

More information

ANTIBIOTICS. 21 st century time bomb. By Keith Wassung

ANTIBIOTICS. 21 st century time bomb. By Keith Wassung ANTIBIOTICS 21 st century time bomb By Keith Wassung The first antibiotic, penicillin, became widely available in 1940. Antibiotics have since become a popular weapon in the medical arsenal against disease.

More information

Microbiology ( Bacteriology) sheet # 7

Microbiology ( Bacteriology) sheet # 7 Microbiology ( Bacteriology) sheet # 7 Revision of last lecture : Each type of antimicrobial drug normally targets a specific structure or component of the bacterial cell eg:( cell wall, cell membrane,

More information

UTI Dr S Mathijs Department of Pharmacology

UTI Dr S Mathijs Department of Pharmacology UTI Dr S Mathijs Department of Pharmacology Introduction Responsible for > 7 million consultations annually 15% of all antibiotic prescriptions 40% of all hospital acquired infections Significant burden

More information

American Association of Feline Practitioners American Animal Hospital Association

American Association of Feline Practitioners American Animal Hospital Association American Association of Feline Practitioners American Animal Hospital Association Basic Guidelines of Judicious Therapeutic Use of Antimicrobials August 1, 2006 Introduction The Basic Guidelines to Judicious

More information

Antimicrobial agents

Antimicrobial agents Bacteriology Antimicrobial agents Learning Outcomes: At the end of this lecture, the students should be able to: Identify mechanisms of action of antimicrobial Drugs Know and understand key concepts about

More information

GUIDELINES FOR USERS ANTIMICROBIAL REFERENCE LABORATORY ANTIMICROBIAL ASSAY SERVICE. 18th Edition

GUIDELINES FOR USERS ANTIMICROBIAL REFERENCE LABORATORY ANTIMICROBIAL ASSAY SERVICE. 18th Edition ANTIMICROBIAL REFERENCE LABORATORY ANTIMICROBIAL ASSAY SERVICE GUIDELINES FOR USERS 18th Edition 2015 Earlier editions should be destroyed Antimicrobial Reference Laboratory Department of Medical Microbiology

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Metrobactin 500 mg tablets for dogs and cats (AT, BE, BG, CY, CZ, DE, EL, ES, FR, HR, HU, IE, IT, LU, NL, PL, PT, RO, SI,

More information

Eradiaction of Resistant Organisms:

Eradiaction of Resistant Organisms: Eradiaction of Resistant Organisms: Can we do it and does it help? Noah Lechtzin, MD; MHS Director, Adult CF Program Outline Evidence resistant organisms are bad MRSA, B cepacia, Pseudomonas, Fungal infections

More information

Ear drops suspension. A smooth, uniform, white to off-white viscous suspension.

Ear drops suspension. A smooth, uniform, white to off-white viscous suspension. SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT OTOMAX EAR DROPS SUSPENSION 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of the veterinary medicinal product contains:

More information

BUGS and DRUGS Part 1 March 6, 2013 Marieke Kruidering- Hall

BUGS and DRUGS Part 1 March 6, 2013 Marieke Kruidering- Hall BUGS and DRUGS Part 1 March 6, 2013 Marieke Kruidering- Hall BIOGRAPHY: Marieke Kruidering- Hall is Associate Professor in the Department of Cellular & Molecular Pharmacology. She was born in the Netherlands.

More information

Antibiotics & Resistance

Antibiotics & Resistance What are antibiotics? Antibiotics & esistance Antibiotics are molecules that stop bacteria from growing or kill them Antibiotics, agents against life - either natural or synthetic chemicals - designed

More information

Nocardicin A-F,1976, Nocardia uniformis sp. (Fujisawa) Sulfazecin, 1981, Pseudomonas acidophila (Takeda

Nocardicin A-F,1976, Nocardia uniformis sp. (Fujisawa) Sulfazecin, 1981, Pseudomonas acidophila (Takeda Cephamycins Cephamycins Antibiotics III. Cephamycin A-C, 1971, Str. lipmanii 7 -Methoxy group: Somewhat diminished antibacterial activity Resistant to a wide range of ß-lactamase enzymes 3-CH 2 -carbamoyl

More information

INTRODUCTION TO WILDLIFE PHARMACOLOGY. Lisa Fosco Wildlife Rehabilitation Manager Toronto Wildlife Centre

INTRODUCTION TO WILDLIFE PHARMACOLOGY. Lisa Fosco Wildlife Rehabilitation Manager Toronto Wildlife Centre INTRODUCTION TO WILDLIFE PHARMACOLOGY Lisa Fosco Wildlife Rehabilitation Manager Toronto Wildlife Centre General Pharmacology Factors That Affect Drug Absorption The dosage form Blood supply to the area

More information

Responsible use of antibiotics

Responsible use of antibiotics Responsible use of antibiotics Uga Dumpis MD, PhD Department of Infectious Diseases and Infection Control Pauls Stradiņs Clinical University Hospital Challenges in the hospitals Antibiotics are still effective

More information

Parasites and their vectors

Parasites and their vectors Parasites and their vectors ThiS is a FM Blank Page Yvonne Ai Lian Lim Indra Vythilingam Editors Parasites and their vectors A special focus on Southeast Asia Editors Yvonne Ai Lian Lim Indra Vythilingam

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT RONAXAN 20mg Tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Active substance : Doxycycline (as doxycycline

More information